Presentation TCT 2015 Considerations Regarding Renal Function in the Patient With Atrial Fibrillation Presenter: Gerhard C. Schuler, C. Michael Gibson October 14, 2015
News Conference News TCT 2015 LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients Yael L. Maxwell October 14, 2015
Presentation TCT 2015 TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis October 13, 2015
Presentation TCT 2015 TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial) Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen October 13, 2015
Presentation TCT 2015 TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell October 13, 2015
Presentation TCT 2015 TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder October 13, 2015
Presentation TCT 2015 TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study Presenter: Michael A. Weber, Stephen G. Worthley October 13, 2015
Presentation TCT 2015 TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar October 13, 2015
Presentation TCT 2015 TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo October 13, 2015
Presentation TCT 2015 TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair October 13, 2015
Presentation TCT 2015 TCT 84: Enhanced Circumferential Ablation Using a Multielectrode Bipolar/Unipolar Over-the-Wire Renal Denervation RF Catheter System With Closed-Loop Sensing Presenter: Michael A. Weber, Stephen G. Worthley, Elazer R. Edelman October 13, 2015
Presentation TCT 2015 TCT 83: Long-term (24-Month) Blood Pressure Results of Catheter-Based Renal Artery Denervation SYMPLICITY HTN-3 Randomized Controlled Trial Presenter: Michael A. Weber, Stephen G. Worthley, Deepak L. Bhatt October 13, 2015
Presentation TCT 2015 Guidewire-Based Autonomic Neural Sensing From the Artery Lumen: Applications in Renal Denervation, Cancer, and Dysautonomias (Autonomix) Presenter: Robert S. Schwartz October 13, 2015
News Industry News Medtronic CoreValve® System Shows Positive Clinical Outcomes in New Patient Populations October 13, 2015
News Conference News TCT 2015 Companies With Innovative Technologies Compete in TCT Shark Tank October 13, 2015
Presentation TCT 2015 Endovascular Interventions: Lower-Extremity, Aorta, Renal, and Carotid Disease Presenter: Kenneth Rosenfield, Sahil A. Parikh October 12, 2015
Presentation TCT 2015 Severe Renal Disease and TAVR: Thoughtful Commentary on the Case Presenter: Howard C. Herrmann, Patrick T. O'Gara, Charles J. Davidson October 12, 2015
Presentation TCT 2015 Severe Renal Disease and TAVR: Case Presentation Presenter: Howard C. Herrmann, Patrick T. O'Gara, S. Chiu Wong October 12, 2015
News Industry News Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants October 12, 2015